Early phase Amyloid‐PET reproduces metabolic signatures of cognitive decline in Parkinson's disease
Campbell Le Heron, William Aye, Megan Stark, Kyla‐Louise Horne, Daniel J Myall, Toni Pitcher, Mustafa Almuqbel, Ross Keenan, John C Dalrymple‐Alford, Tim J Anderson, Tracy R Melzer · 2025
Read Early phase Amyloid‐PET reproduces metabolic signatures of cognitive decline in Parkinson's disease by Campbell Le Heron, William Aye, Megan Stark, Kyla‐Louise Horne, Daniel J Myall, Toni Pitcher, Mustafa Almuqbel, Ross Keenan, John C Dalrymple‐Alford, Tim J Anderson, Tracy R Melzer (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11715625.txt.
Description
Campbell Le Heron and co-authors show that the opening minutes of an amyloid brain scan can stand in for blood flow maps in Parkinson's disease, in this 2025 study. Late scan images reveal amyloid, a marker of Alzheimer's disease, but say nothing about circulation. One hundred fifteen patients across the thinking-decline spectrum had dual-phase scans, MRI, and cognitive tests.
Early uptake matched MRI perfusion across wide brain areas. Low early uptake also tracked worse thinking in the very regions where Parkinson's decline usually starves metabolism, regardless of amyloid status. One combined scan could thus serve two diagnostic jobs.
Catalog record
| CREATOR | Campbell Le Heron, William Aye, Megan Stark, Kyla‐Louise Horne, Daniel J Myall, Toni Pitcher, Mustafa Almuqbel, Ross Keenan, John C Dalrymple‐Alford, Tim J Anderson, Tracy R Melzer |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |